# Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use, Article 65

Extent: E+W+S+N.I.

In consultation with the Member States and the parties concerned, the Commission shall draw up and publish detailed guidance concerning in particular:
(a) the wording of certain special warnings for certain categories of medicinal products;
(b) the particular information needs relating to non-prescription medicinal products;
(c) the legibility of particulars on the labelling and package leaflet;
(d) the methods for the identification and authentication of medicinal products;
(e) the list of excipients which must feature on the labelling of medicinal products and the way in which these excipients must be indicated;
(f) harmonised provisions for the implementation of Article 57.

---
Source: https://www.legislation.gov.uk/eudr/2001/83/article/65 (the official version)
Page: https://openlegislation.uk/eu-directive-2001-83/article-65
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.